NOV 04, 2021
Comprehensive Ophthalmology, Glaucoma
0.5 General AMA PRA Category 1 Credits™
Drs. Lorraine Provencher and Matthew Emanuel join the show to discuss current nonsurgical management options for glaucoma patients. The panel reviews new topical therapy such as rho kinase inhibitors, injectable therapy, and the role of selective laser trabeculoplasty (SLT) based on the the Laser in Glaucoma and Ocular Hypertension (LiGHT) trial.
Release: November 4, 2021; expires November 4, 2024
Disclosures: Dr. Emanuel receives lecture fees from Aerie Pharmaceuticals. Drs. Provencher and Sridhar report no relevant financial disclosures.
Learning Objective: Upon completion of this episode, the listener should be able to describe evolving standards of care for the management of glaucoma or the outcomes from recent research and how these impact patient care decisions.
Audience: This activity is intended for comprehensive ophthalmologists.
Accreditation: The American Academy of Ophthalmology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The American Academy of Ophthalmology designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits.TM Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Hardware/Software Requirements: This learning activity requires a current web browser and speaker or headset capable of playing streaming audio.